Literature DB >> 18032570

Cytokine profiles in primary and secondary pulmonary granulomas of Guinea pigs with tuberculosis.

Lan H Ly1, Murat I Russell, David N McMurray.   

Abstract

The cytokine mRNA profiles of primary (arising from inhaled bacilli) and secondary (arising from hematogenous reseeding of the lung) granulomas from the lung lobes of bacillus Calmette-Guérin (BCG)-vaccinated and unimmunized guinea pigs challenged with virulent Mycobacterium tuberculosis by the pulmonary route were assessed in situ using laser capture microdissection (LCM) at 6 weeks after infection. The challenge dose chosen was so low that some lung lobes did not receive an implant from the airway. In unimmunized guinea pigs, some lobes contained either large, necrotic primary lesions or small, non-necrotic secondary lesions, or both. The lobes of BCG-vaccinated animals contained only non-necrotic primary tubercles, and no secondary lesions were visible. Real-time PCR analysis of the acquired RNA clearly demonstrated that primary tubercles from BCG-vaccinated guinea pigs were overwhelmed with mRNA from the anti-inflammatory cytokine, transforming growth factor (TGF)-beta, with some IFN-gamma and IL-12p40 mRNA. In contrast, primary lesions from unimmunized animals were dominated by proinflammatory TNF-alpha mRNA. The cytokine mRNA profile of secondary lesions from unimmunized animals was strikingly similar to the profile of primary lesions from BCG-vaccinated guinea pigs (i.e., a predominance of TGF-beta mRNA with some IL-12p40 and IFN-gamma mRNA), indicating that the lung lobes from which these lesions were retrieved had been naturally "vaccinated" by the time the bloodborne bacilli returned to the lung at 3 to 4 weeks after infection. Furthermore, cytokine mRNA analysis of splenic granulomas from nonvaccinated and vaccinated animals showed close resemblance to primary granulomas recovered from the lungs of the same animal, that is, high levels of TNF-alpha mRNA in unimmunized animals, and mostly TGF-beta mRNA in BCG-vaccinated guinea pigs. Taken together, these data indicate that mycobacteria returning to the lungs of unimmunized guinea pigs 3 to 4 weeks after infection induce a local cytokine response that is fundamentally different from the response to inhaled bacilli and is reminiscent of the primary response in a vaccinated animal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032570      PMCID: PMC2274948          DOI: 10.1165/rcmb.2007-0326OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  20 in total

1.  The pathogenesis of minimal pulmonary tuberculosis; a study of 1,225 necropsies in cases of sudden and unexpected death.

Authors:  E M MEDLAR
Journal:  Am Rev Tuberc       Date:  1948-12

Review 2.  What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge.

Authors:  E D Chan; J Chan; N W Schluger
Journal:  Am J Respir Cell Mol Biol       Date:  2001-11       Impact factor: 6.914

3.  Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs.

Authors:  E H Wiegeshaus; D N McMurray; A A Grover; G E Harding; D W Smith
Journal:  Am Rev Respir Dis       Date:  1970-09

4.  Influence of BCG vaccination on the pathogenesis of experimental airborne tuberculosis.

Authors:  D W Smith; J S Fok; R S Ho; G E Harding; E Wiegeshaus; P K Arora
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1975

5.  Evidence of a "silent" bacillemia in primary tuberculosis.

Authors:  W W Stead; J H Bates
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

6.  Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs.

Authors:  D W Smith; D N McMurray; E H Wiegeshaus; A A Grover; G E Harding
Journal:  Am Rev Respir Dis       Date:  1970-12

7.  Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia.

Authors:  R S Ho; J S Fok; G E Harding; D W Smith
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226

8.  Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs.

Authors:  Shannon Sedberry Allen; David N McMurray
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Host-parasite relationships in experimental airborne tuberculosis. VI. Influence of vaccination with Bacille Calmette-Guérin on the onset and/or extent of hematogenous dissemination of virulent Mycobacterium tuberculosis to the lungs.

Authors:  G E Harding; D W Smith
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

10.  A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatment.

Authors:  D W Smith; V Balasubramanian; E Wiegeshaus
Journal:  Tubercle       Date:  1991-09
View more
  28 in total

1.  The stringent response is required for full virulence of Mycobacterium tuberculosis in guinea pigs.

Authors:  Lee G Klinkenberg; Jong-Hee Lee; William R Bishai; Petros C Karakousis
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

2.  Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assay.

Authors:  Lance K Ching; Farah Mompoint; Jeffrey A Guderian; Alex Picone; Ian M Orme; Rhea N Coler; Steven G Reed; Susan L Baldwin
Journal:  J Immunol Methods       Date:  2011-08-03       Impact factor: 2.303

Review 3.  Inhaled drug delivery for tuberculosis therapy.

Authors:  Pavan Muttil; Chenchen Wang; Anthony J Hickey
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

Review 4.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

5.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

6.  Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Vaccine       Date:  2012-01-11       Impact factor: 3.641

7.  Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.

Authors:  Shihoko Komine-Aizawa; Toshio Yamazaki; Tsuyoshi Yamazaki; Shin-Ichiro Hattori; Yuji Miyamoto; Naoki Yamamoto; Shinji Haga; Masahiko Sugitani; Mitsuo Honda; Satoshi Hayakawa; Saburo Yamamoto
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

8.  Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.

Authors:  Liyou Qiu; Dan Huang; Cystal Y Chen; Richard Wang; Ling Shen; Yun Shen; Robert Hunt; James Estep; Barton F Haynes; William R Jacobs; Norman Letvin; George Du; Zheng W Chen
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

9.  Neutralization of TNFalpha alters inflammation in guinea pig tuberculous pleuritis.

Authors:  Lan H Ly; Amminikutty Jeevan; David N McMurray
Journal:  Microbes Infect       Date:  2009-04-21       Impact factor: 2.700

10.  Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.

Authors:  Zhou Xing; Christine T McFarland; Jean-Michel Sallenave; Angelo Izzo; Jun Wang; David N McMurray
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.